Gene: TRABD
Official Full Name: TraB domain containingprovided by HGNC
Gene Summary: Enables mitochondrion-mitochondrion outer membrane tether activity. Involved in mitochondrial fusion. Located in mitochondrion. Is active in mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06378 | TRABD Knockout cell line (HeLa) | Human | TRABD | 1:3~1:6 | Negative | Online Inquiry |
KO06379 | TRABD Knockout cell line (HCT 116) | Human | TRABD | 1:2~1:4 | Negative | Online Inquiry |
KO06380 | TRABD Knockout cell line (HEK293) | Human | TRABD | 1:3~1:6 | Negative | Online Inquiry |
KO06381 | TRABD Knockout cell line (A549) | Human | TRABD | 1:3~1:4 | Negative | Online Inquiry |
TRABD Gene Knockout Cell Lines are specialized cellular models engineered to disrupt the TRABD gene, a critical target for investigating cellular processes such as metabolism, signaling pathways, and disease mechanisms. These cell lines are generated using advanced gene editing technologies like CRISPR-Cas9, facilitating precise, heritable alterations in the genome. The knockout of the TRABD gene allows researchers to observe the consequent phenotypic changes and helps elucidate its role in various cellular functions.
Functionally, TRABD Gene Knockout Cell Lines enable scientists to dissect the contributions of the TRABD protein in cellular mechanisms. By eliminating its expression, researchers can explore the downstream effects on metabolic pathways, cellular proliferation, apoptosis, and response to environmental stimuli. This provides valuable insight into how TRABD is implicated in health and disease, making these cell lines essential tools in the fields of molecular biology and biomedical research.
The scientific importance of TRABD Gene Knockout Cell Lines extends into both research and clinical settings, allowing for the modeling of diseases such as cancer and metabolic disorders. These modified cells can be effectively used in high-throughput drug screening, providing a platform for the evaluation of therapeutic compounds that may target the TRABD-related biological pathways.
One significant advantage of our TRABD Gene Knockout Cell Lines is their enhanced reliability and reproducibility, compared to alternative models, such as transient knockdown systems that may not provide stable and enduring results. Additionally, our cell lines are validated for specific applications, ensuring accuracy in experimental outcomes.
By employing these knockout cell lines, researchers can take advantage of a robust model system that drives innovative discoveries leading to new therapeutic strategies. The TRABD Gene Knockout Cell Lines represent an indispensable resource for advancing our understanding of gene function and therapeutic targeting.
Our company is dedicated to providing high-quality biological products, backed by years of expertise in genetic engineering and cell biology. We strive to equip researchers and clinicians with the tools needed to push the boundaries of science and medicine, ensuring the highest standards of performance in every product we offer.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.